von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy.

MLA

Smith, D. R., et al. “Von Willebrand Factor Antigen, von Willebrand Factor Propeptide and ADAMTS13 Activity in TIA or Ischaemic Stroke Patients Changing Antiplatelet Therapy.” Journal of the Neurological Sciences, vol. 463, Aug. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jns.2024.123118.

APA

Smith, D. R., Lim, S. T., Murphy, S. J. X., Hickey, F. B., Offiah, C., Murphy, S. M., Collins, D. R., Coughlan, T., O’Neill, D., Egan, B., O’Donnell, J. S., O’Sullivan, J. M., & McCabe, D. J. H. (2024). von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy. Journal of the Neurological Sciences, 463, N.PAG. https://doi.org/10.1016/j.jns.2024.123118

Chicago

Smith, D.R., S.T. Lim, S.J.X. Murphy, F.B. Hickey, C. Offiah, S.M. Murphy, D.R. Collins, et al. 2024. “Von Willebrand Factor Antigen, von Willebrand Factor Propeptide and ADAMTS13 Activity in TIA or Ischaemic Stroke Patients Changing Antiplatelet Therapy.” Journal of the Neurological Sciences 463 (August): N.PAG. doi:10.1016/j.jns.2024.123118.